Abstract
Epstein-Barr virus-related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein-Barr virus (EBV) local proliferation and thus could be an interesting target. Brentuximab vedotin could become a new helpful tool.
Author supplied keywords
Cite
CITATION STYLE
APA
Montes, L., Tredez, E., Yzet, C., Delette, C., Chatelain, D., Lebon, D., … Marolleau, J. P. (2020). Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn’s disease, treated with monoclonal antibody anti-CD30. Clinical Case Reports, 8(6), 958–961. https://doi.org/10.1002/ccr3.2721
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free